Market Overview:
The global nicotine gum market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing number of smokers quitting smoking and the growing demand for smokeless tobacco products. In terms of type, the 2 mg/piece of gum dosage segment is expected to dominate the market during the forecast period owing to its high demand from withdrawal clinics and medical practices. However, with an increasing number of individual smokers using nicotine gums as an aid to quit smoking, the 4 mg/piece of gum dosage segment is projected to grow at a higher CAGR during the forecast period. Geographically, North America dominates the global nicotine gum market followed by Europe and Asia Pacific.
Product Definition:
Nicotine gum is a type of chewing gum that contains nicotine, a stimulant drug. It is used to help people stop smoking tobacco cigarettes. Nicotine gum helps reduce cravings for cigarettes and other tobacco products. It also helps relieve symptoms of nicotine withdrawal.
2 mg/piece of gum dosage:
2 mg/piece of gum is the dosage for nicotine chewing gums. These products are available in different flavors such as original, menthol, and fruit & nuts. The product is manufactured by many companies including Japan Tobacco Inc., British American Tobacco Plc., and Philip Morris International Inc.
4 mg/piece of gum dosage:
Nicotine Gums are available in different flavors such as original, menthol, and mint. The nicotine content in these products is 4 mg per piece. It is used for treating smoking addiction and to stop the desire to smoke. These products are also useful for people who are trying to quit smoking as it gives them a boost of nicotine which makes them want to quit smoking thus making it easier for them to do so.
Application Insights:
Based on application, the global nicotine gum market is segmented into individual smokers, medical practitioners and others. Withdrawal clinics held the largest share of the overall revenue in 2017 owing to high usage rates among individuals who have quit smoking tobacco and other forms of nicotine intake. The use of these products helps reduce cravings for cigarettes which may lead to a successful quitting attempt.
Medical practitioners are expected to be at higher risk of developing cardiovascular diseases due to constant exposure while treating patients with underlying heart conditions or during surgeries where they need nitroglycerine tablets for relief from angina pectoris attacks. This factor is anticipated to increase demand for nicotine gums in medical practices over the forecast period as it has been proven that these products help dilate blood vessels thereby lowering blood pressure levels significantly without any negative side effects as compared with conventional therapies used across various healthcare settings globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high smoking prevalence and rising awareness about e-cigarettes among individuals as well as healthcare professionals. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to increasing demand for nicotine replacement therapy products, such as gum, lozenges, patches & chewing gums, which are used for quitting smoking. Moreover, growing awareness regarding various substitutes of tobacco such as e-cigarettes will drive regional growth further.
The European market also held a significant share in terms of revenue and is expected to grow at a considerable rate over the forecast period owing tobuyer's confidence in these products coupled with favorable government regulations that support innovation pertaining tobaccorelated cessation aids & therapies along with raising public health concerns about secondhand smoke exposure caused by cigarettes resulting into restrictions on sales.
Growth Factors:
- Increasing awareness about the harmful effects of smoking and the benefits of quitting smoking
- Growing number of smokers looking for an alternative to cigarettes
- Increased focus on public health and anti-smoking campaigns
- Availability of nicotine gum in different flavors
- Reduction in prices due to increased competition
Scope Of The Report
Report Attributes
Report Details
Report Title
Nicotine Gum Market Research Report
By Type
2 mg/piece of gum dosage, 4 mg/piece of gum dosage
By Application
Withdrawal Clinics, Medical Practice, Individual Smokers, Others
By Companies
Novartis, Perrigo Company, Pharmacia, Fertin Pharma, Revolymer, Johnson & Johnson, Alchem International, Cambrex Corporation, GlaxoSmithKline, Reynolds American, Dr. Reddy's Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Nicotine Gum Market Report Segments:
The global Nicotine Gum market is segmented on the basis of:
Types
2 mg/piece of gum dosage, 4 mg/piece of gum dosage
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Withdrawal Clinics, Medical Practice, Individual Smokers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Perrigo Company
- Pharmacia
- Fertin Pharma
- Revolymer
- Johnson & Johnson
- Alchem International
- Cambrex Corporation
- GlaxoSmithKline
- Reynolds American
- Dr. Reddy's Laboratories
Highlights of The Nicotine Gum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2 mg/piece of gum dosage
- 4 mg/piece of gum dosage
- By Application:
- Withdrawal Clinics
- Medical Practice
- Individual Smokers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nicotine Gum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nicotine gum is a type of chewing gum that contains nicotine. Nicotine gum is used to help people quit smoking cigarettes.
Some of the major companies in the nicotine gum market are Novartis, Perrigo Company, Pharmacia, Fertin Pharma, Revolymer, Johnson & Johnson, Alchem International, Cambrex Corporation, GlaxoSmithKline, Reynolds American, Dr. Reddy's Laboratories.
The nicotine gum market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nicotine Gum Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nicotine Gum Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nicotine Gum Market - Supply Chain
4.5. Global Nicotine Gum Market Forecast
4.5.1. Nicotine Gum Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nicotine Gum Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nicotine Gum Market Absolute $ Opportunity
5. Global Nicotine Gum Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nicotine Gum Market Size and Volume Forecast by Type
5.3.1. 2 mg/piece of gum dosage
5.3.2. 4 mg/piece of gum dosage
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nicotine Gum Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nicotine Gum Market Size and Volume Forecast by Application
6.3.1. Withdrawal Clinics
6.3.2. Medical Practice
6.3.3. Individual Smokers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nicotine Gum Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nicotine Gum Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nicotine Gum Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nicotine Gum Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nicotine Gum Demand Share Forecast, 2019-2026
9. North America Nicotine Gum Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nicotine Gum Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nicotine Gum Market Size and Volume Forecast by Application
9.4.1. Withdrawal Clinics
9.4.2. Medical Practice
9.4.3. Individual Smokers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nicotine Gum Market Size and Volume Forecast by Type
9.7.1. 2 mg/piece of gum dosage
9.7.2. 4 mg/piece of gum dosage
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nicotine Gum Demand Share Forecast, 2019-2026
10. Latin America Nicotine Gum Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nicotine Gum Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nicotine Gum Market Size and Volume Forecast by Application
10.4.1. Withdrawal Clinics
10.4.2. Medical Practice
10.4.3. Individual Smokers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nicotine Gum Market Size and Volume Forecast by Type
10.7.1. 2 mg/piece of gum dosage
10.7.2. 4 mg/piece of gum dosage
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nicotine Gum Demand Share Forecast, 2019-2026
11. Europe Nicotine Gum Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nicotine Gum Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nicotine Gum Market Size and Volume Forecast by Application
11.4.1. Withdrawal Clinics
11.4.2. Medical Practice
11.4.3. Individual Smokers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nicotine Gum Market Size and Volume Forecast by Type
11.7.1. 2 mg/piece of gum dosage
11.7.2. 4 mg/piece of gum dosage
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nicotine Gum Demand Share, 2019-2026
12. Asia Pacific Nicotine Gum Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nicotine Gum Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nicotine Gum Market Size and Volume Forecast by Application
12.4.1. Withdrawal Clinics
12.4.2. Medical Practice
12.4.3. Individual Smokers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nicotine Gum Market Size and Volume Forecast by Type
12.7.1. 2 mg/piece of gum dosage
12.7.2. 4 mg/piece of gum dosage
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nicotine Gum Demand Share, 2019-2026
13. Middle East & Africa Nicotine Gum Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nicotine Gum Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nicotine Gum Market Size and Volume Forecast by Application
13.4.1. Withdrawal Clinics
13.4.2. Medical Practice
13.4.3. Individual Smokers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nicotine Gum Market Size and Volume Forecast by Type
13.7.1. 2 mg/piece of gum dosage
13.7.2. 4 mg/piece of gum dosage
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nicotine Gum Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nicotine Gum Market: Market Share Analysis
14.2. Nicotine Gum Distributors and Customers
14.3. Nicotine Gum Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novartis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Perrigo Company
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pharmacia
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fertin Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Revolymer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alchem International
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cambrex Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GlaxoSmithKline
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Reynolds American
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Dr. Reddy's Laboratories
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook